AzTrials
AzTrials

Trauma InjuryETICNCT07046858

Predictive Accuracy of PLR and PNR in Detecting ETIC

An observational study of Trauma Injury and Coagulopathy, run by Jubilee Mission Medical College and Research Institute at 1 site in India.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Observational study to know what is the predictive accuracy of platelet-neutrophil ratio (PNR) and platelet-lymphocyte ratio (PLR) done in patients presenting to ED( emergency department)within 6 hours of trauma; in detecting early trauma induced coagulopathy during hospital admission Read more about this study

Who is it for?
Ages 12 years and olderHealthy volunteers can take part
Conditions the study is for
Trauma Injury, Coagulopathy
How many people
250 participants
Where
1 siteIndia
Study dates
17 Oct 2023to 27 Nov 2025
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: All patients with trauma AND Presenting to ED within 6 hrs of the event AND The ED Physician sends coagulation profile

Who may be able to join

  • All patients with trauma AND
  • Presenting to ED within 6 hours of the event AND
  • The ED Physician sends coagulation profile

Who cannot join

  • Treated with intravenous fluids, drugs, whole blood and blood products elsewhere
  • Patients admitted with a non-mechanical mechanism of injury, specifically drowning, hanging,or burns, as these mechanisms may result in a different biologic response than mechanical trauma
  • Patients on known medications affecting coagulation profile or hemogram
  • Patients with known chronic liver disease, chronic renal failure, malignancy, hematological disorders
  • Patients not consenting for the study

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dr Siju V Abraham, MBBS MD contact

+919447754321

sijuvabraham@gmail.com

Dr Amrutha T, MBBS contact

+918547196022

amruthathotten@gmail.com

India1 site, 1 recruiting
  • Jubilee Mission Medical College

    Thrissur, Kerala, 670303

    Dr Siju V Abraham, MBBS MD, +91 94477 54321, sijuvabraham@gmail.com

    Dr Amrutha T, MBBS

    Recruiting

Other trials in India

About this study

Official title: Predictive Accuracy of Platelet Lymphocyte Ratio & Platelet Neutrophil Ratio in Detecting Early Trauma Induced Coagulopathy

Observational study to know what is the predictive accuracy of platelet-neutrophil ratio (PNR) and platelet-lymphocyte ratio (PLR) done in patients presenting to ED( emergency department)within 6 hours of trauma; in detecting early trauma induced coagulopathy during hospital admission

Read the detailed description

Trauma has a significant impact on the wellbeing and healthcare for the populations. Millions of patients seek medical help as a result of trauma, with a substantial proportion of patients suffering from life-changing or life-limiting injuries. The leading cause of traumatic death worldwide is road traffic collision, followed by suicide and homicide.(4) The role of platelets in the hemostasis and coagulation is crucial. Platelet interaction with lymphocytes, neutrophils, and monocytes modifies both the innate and adaptive immune responses.Platelets stick to the damaged endothelium and recruit leukocytes to the sites of injury.

Lymphocytes are the major cellular components of the humoral and cell-mediated immune system which include T, B, and natural killer cells. Platelet-lymphocyte ratio (PLR), platelet- neutrophil ratio (PNR) could reflect the balance between the body response to inflammation and immunity mediators Previously, few studies have tested the usefulness of PLR, PNR for predicting the outcomes in stroke , cardiovascular diseases. abdominal trauma, ARDS (Acute Respiratory Distress Syndrome) \& sepsis. I would like to do a study, where the results could be utilized in a resource limited hospital , for early referral and the prognostic value of these biomarkers in predicting ETIC in trauma.

The present study hypothesize that the on-admission PLR , PNR values would help early risk stratification and timely management of trauma patients which subsequently improve the outcomes

Keywords
Early trauma induced coagulopathy
Medical subject headings
Accidental Injuries, Hemostatic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07046858
Study groupRoleWhat they receive
Trauma patients with and without ETICAll the trauma patients coming to ED for whom the physician send investigations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1. Sensitivity, specificity, positive and negative predictive value

    PLR and PNR ratio in predicting in-hospital transfusion requirement during index hospital admission.

    Measured: 24 hours

Secondary outcomes (4)
  1. Compare the AUROC ( Area Under the Receiver Operating Characteristic Curve) of PLR and PNR ratio in predicting in-hospital transfusion requirement during index hospital admission

    PLR and PNR ratio in predicting in-hospital 30 day mortality

    Measured: 24 hours

  2. Compare the AUROC of PLR and PNR ratio in predicting prolonged ventilatory support (>21 days)

    Prolonged ventilators support

    Measured: 24 hours

  3. Compare the incidence of emergent surgery, renal replacement therapy amongst patients developing ETIC and those who do not during the duration of hospital stay or within 30 days (whichever is earlier)

    Renal replacement therapy in patients with ETIC

    Measured: 24hours

  4. Compare the length of hospital stay, total number of surgeries, total intensive care days in numbers amongst patients developing ETIC and those who do not during the duration of hospital stay or within 30 days (whichever is earlier)

    length of hospital stay, total number of surgeries, total intensive care days in numbers amongst patients developing ETIC and those who do not during the duration of hospital stay or within 30 days

    Measured: 24hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jul 2025
  2. Study start17 Oct 2023
  3. Primary completion27 Oct 2025 (estimated)
  4. Study completion27 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
250 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07046858
Sponsor's protocol ID
47/23/IEC/JMMC&RI
Acronym
ETIC
Status last verified
Jun 2025
First submitted
9 Aug 2023
Last updated
2 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma Injury and Coagulopathy, run by Jubilee Mission Medical College and Research Institute at 1 site in India.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dr Siju V Abraham, MBBS MD (+919447754321, sijuvabraham@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1. Sensitivity, specificity, positive and negative predictive value (time frame: 24 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in